CHV Fellowship Workshop 4/4: Advancing Life Sciences Innovation & Bringing Breakthroughs to Market

​Advancing Life Sciences Innovation & Bringing Breakthroughs to Market

​CHV Fellowship | Workshop 4/4 with Richie Lou

​Why do some scientific breakthroughs become treatments that reach patients, while others never make it out of the lab? Getting a new therapy to market depends on more than the science. It also depends on funding, competition, pricing, and timing.

​Life sciences is one of the most innovative and valuable parts of healthcare, and it is changing fast. New kinds of treatments like cell and gene therapies are entering the pipeline, and AI is changing how drugs are discovered. Meanwhile, more competition, shorter product lifecycles, and growing pressure on prices are changing how companies decide what to build and how to bring it to patients. These forces affect pharmaceutical and biotech companies, and also the investors, payers, providers, and policymakers they work with.

​In this workshop, Richie Lou, Expert Associate Partner in Life Sciences at McKinsey & Company, will share how industry leaders think about innovation and value creation, and explore these questions:

• ​Where is value created in healthcare, and why does developing new therapies and devices remain one of the most attractive parts of the market?

• ​Where is the next wave of innovation coming from, and how are funding markets and M&A shaping which ideas move forward?

• ​What forces will reshape the life sciences industry over the next 5–10 years?

• ​What does it take to successfully bring a breakthrough to market in today’s environment?